Jaehyun Park Resigns as CEO of Hanmi Pharm... "The 'Im Sungki Spirit' Must Be Upheld"
Jaehyun Park, CEO of Hanmi Pharmaceutical, has announced his intention to step down from his position at the end of his current term.
On March 12, Park issued a statement saying, "With the conclusion of this term, I intend to resign from my role as CEO of Hanmi Pharmaceutical." He added, "As long as Hanmi’s founding philosophy, the 'Lim Sungki Spirit,' and the professional management system remain intact, I believe the company will continue to move in the right direction."
Park referenced a recent statement from Youngsook Song, Chairwoman of Hanmi Group, noting, "I take seriously her emphasis on the 'Lim Sungki Spirit,' which is Hanmi’s core identity, and the principles of the next-generation management system." He continued, "I understand this as a reaffirmation that Hanmi Pharmaceutical must move forward based on the 'Lim Sungki Spirit' through a professional management system."
Park also stated, "I do not believe that the professional manager must necessarily be myself," and added, "As long as the principle of the 'Lim Sungki Spirit' remains unwavering, Hanmi’s direction can remain true."
He further urged major shareholders and the board of directors, "While management philosophies and directions may differ, I ask that you uphold the 'Lim Sungki Spirit,' which is the foundation of Hanmi, along with the value of quality management."
Additionally, Park emphasized that employees should not face any disadvantages for having supported him, stating, "I will take full responsibility for everything."
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
On the afternoon of the same day, Hanmi Pharmaceutical’s board of directors held a meeting and nominated Sangyeon Hwang, Head of the Private Equity (PE) division at HB Investment, as the next CEO. The board also plans to propose the appointment of Nayoung Kim, Head of New Product Development at Hanmi Pharmaceutical, as an inside director at the regular general shareholders’ meeting scheduled for the end of this month. In addition, Taejun Han, President of Ghent University Global Campus, and former National Assembly member Ibae Chae, will be newly appointed as outside directors.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.